Reported 4,000 shares, unchanged from the prior quarter.
Reported value -11.1%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 7000 |
| 2022-03-31 | 9000 |
| 2022-06-30 | 8000 |
| 2022-09-30 | 6000 |
| 2022-12-31 | 3000 |
| 2023-03-31 | 0 |
| 2023-09-30 | 0 |
| 2023-12-31 | 0 |
| 2024-03-31 | 0 |
| 2024-06-30 | 0 |
| 2024-09-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2024 | Reduced | 0 | -2,135 (-100.0%) | 0 | $0 | 2024-10-16 | |
| Q2 2024 | Unchanged | 2,135 | 0 (0.0%) | 0 | $0 | 2024-07-17 | |
| Q1 2024 | Unchanged | 2,135 | 0 (0.0%) | 0 | $0 | 2024-04-18 | |
| Q4 2023 | Reduced | 2,135 | -1,000 (-31.9%) | 0 | $0 | 2024-01-19 | |
| Q3 2023 | New | 3,135 | +3,135 (0.0%) | 0 | $0 | 2023-10-31 | |
| Q1 2023 | Reduced | 0 | -3,135 (-100.0%) | 0 | $0 | 2023-05-04 | |
| Q4 2022 | Reduced | 3,135 | -865 (-21.6%) | < 0.01% | $3,000 | 2023-02-06 | |
| Q3 2022 | Unchanged | 4,000 | 0 (0.0%) | < 0.01% | $6,000 | 2022-11-14 | |
| Q2 2022 | Unchanged | 4,000 | 0 (0.0%) | < 0.01% | $8,000 | 2022-08-11 | |
| Q1 2022 | Added | 4,000 | +2,500 (166.7%) | < 0.01% | $9,000 | 2022-05-02 | |
| Q4 2021 | New | 1,500 | +1,500 (0.0%) | < 0.01% | $7,000 | 2022-02-09 |
Who else reported the position
242 managers reported SORRENTO THERAPEUTICS INC for Q2 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| STATE STREET CORPORATION | Added | 39,661,099 | +5,700,215 | < 0.01% | $79,719,000 | 33 qtrs |
| BlackRock Inc | Added | 33,950,557 | +11,915,668 | < 0.01% | $68,242,000 | 29 qtrs |
| VANGUARD GROUP INC | Added | 20,896,424 | +4,995,039 | < 0.01% | $42,002,000 | 35 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 6,892,947 | +1,906,514 | < 0.01% | $13,854,000 | 34 qtrs |
| D E Shaw & Co Inc | Reduced | 5,881,402 | -1,360,489 | 0.01% | $11,822,000 | 19 qtrs |
| NORTHERN TRUST CORPORATION | Added | 3,450,139 | +633,201 | < 0.01% | $6,934,000 | 34 qtrs |
| JPMorgan Chase & Co | Reduced | 3,268,517 | -29,062 | < 0.01% | $6,570,000 | 21 qtrs |
| MORGAN STANLEY | Reduced | 2,972,031 | -309,183 | < 0.01% | $5,972,000 | 34 qtrs |
| NORGES BANK | Added | 2,901,483 | +717,900 | < 0.01% | $5,831,981 | 4 qtrs |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | Added | 2,766,904 | +565,217 | < 0.01% | $5,562,000 | 18 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2022
- Filed
- August 11, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 0
- Shared
- 0
- None
- 4,000
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.